dehydroascorbic acid has been researched along with Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connolly, ES; Ducruet, AF; Guo, W; King, RG; Laufer, I; Mack, WJ; Mocco, J; Pinsky, DJ; Zhang, Y | 1 |
1 other study(ies) available for dehydroascorbic acid and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Citric Acid; Dehydroascorbic Acid; Disease Models, Animal; Excipients; Infarction, Middle Cerebral Artery; Injections, Intravenous; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Reperfusion Injury; Sorbitol; Treatment Outcome; Up-Regulation | 2006 |